Patients with chronic
disease often struggle with medication adherence.
Treatment should help relieve their burden, not add it to.
Many existing treatment options bog patients down in a routine of injections or daily oral pills. In certain cases, side effects and the hassle of administering their medications may keep many patients from consistently adhering to their treatment regiments, potentially preventing them from receiving the intended therapeutic benefit of their medicine.
We are committed to freeing patients with chronic disease from their treatment administration burdens with the goal of providing long-term solutions.
We have designed an innovative new implant technology called NanoPortal.
Our NanoPortal technology enables the implants to be designed small enough to be easily inserted under the skin and utilizes a unique mechanism for delivering medication at a steady rate over an extended period.
Tuning our technology to
patient needs.
Nearly every part of the implant design is adjustable, including the size of the device itself along with the nanotubes inside it, the rate of drug delivery, and the length of treatment.
We can carefully tune each component based on what will ensure the appropriate drug delivery over the target treatment duration of the implant. NanoPortal’s versatility may provide an opportunity to deliver a variety of medications for many different chronic conditions.
How can NanoPortal implants potentially change patients’ lives?
The implant’s minimally fluctuating drug release feature is designed to deliver a smoother drug concentration profile for extended periods, which may improve medication tolerability and avoid issues associated with fluctuating release rates.
Since it can deliver medication for as long as 6 months or more once inserted, patients no longer have to worry about administering their own medication on a regular basis. It’s designed to be administered by a healthcare professional during a routine office visit.
As a result, doctors, caregivers and loved ones can rest assured that patients are receiving the intended clinical benefit of their medication.